In gastroesophageal reflux disease, differential gene expression in the duodenum points towards enhanced chylomicron production and secretion

Digestive Diseases and Sciences

Volumn 57, Issue 6, 2012, Pages 1475-1485

  De Vries, Durk R ^a   Ter Linde, José J M ^a   Van Boxel, Ofke S ^a   Van Herwaarden, Margot A ^a   Shephard, Pierre ^b   Geng, Michael M ^b   Schwartz, Matthijs P ^a   Samsom, Melvin ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Nycomed Pharma AG   (Germany)

Author keywords

Apolipoprotein A IV; Cholecystokinin; Duodenum; Gastroesophageal reflux disease; Lipid absorption

Indexed keywords

APOLIPOPROTEIN A4; CHOLECYSTOKININ; CHYLOMICRON; COMPLEMENTARY DNA; COMPLEMENTARY RNA; MESSENGER RNA; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RNA 18S; RNA 28S;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM; DUODENUM BIOPSY; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; LIPID ABSORPTION; MICROARRAY ANALYSIS; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORIMOTOR FUNCTION; STOMACH;

ADULT; APOLIPOPROTEINS A; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHYLOMICRONS; DOWN-REGULATION; DUODENUM; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTON PUMP INHIBITORS; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UP-REGULATION;

EID: 84864276467     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2064-0     Document Type: Article

References (34)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-1920.
2. Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3:543-552. (Pubitemid 40824747)
3. Dent J, El Serag HB, Wallander MA, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2005;54:710-717. (Pubitemid 40559260)
4. Boeckxstaens GE. Review article: the pathophysiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;26: 149-160. (Pubitemid 46985502)
5. Nebel OT, Castell DO. Inhibition of the lower oesophageal sphincter by fat - a mechanism for fatty food intolerance. Gut. 1973;14:270-274.
6. Zerbib F, Bruley DV, Scarpignato C, et al. Endogenous chole-cystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol. 1998;275:G1266-G1273.
7. Perdikis G, Wilson P, Hinder RA, et al. Gastroesophageal reflux disease is associated with enteric hormone abnormalities. Am J Surg. 1994;167:186-191.
8. Khurana RK, Petras JM. Sensory innervation of the canine esophagus, stomach, and duodenum. Am J Anat. 1991;192:293-306.
9. Wank M, Neuhuber WL. Local differences in vagal afferent innervation of the rat esophagus are reflected by neurochemical differences at the level of the sensory ganglia and by different brainstem projections. J Comp Neurol. 2001;435:41-59. (Pubitemid 32448721)
10. Zhang X, Renehan WE, Fogel R. Vagal innervation of the rat duodenum. J Auton Nerv Syst. 2000;79:8-18. (Pubitemid 30100593)
11. Meyer JH, Lembo A, Elashoff JD, Fass R, Mayer EA. Duodenal fat intensifies the perception of heartburn. Gut. 2001;49:624-628. (Pubitemid 32989197)
12. Hobson AR, Khan RW, Sarkar S, Furlong PL, Aziz Q. Development of esophageal hypersensitivity following experimental duodenal acidification. Am J Gastroenterol. 2004;99:813-820. (Pubitemid 39090205)
13. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994;107:271-293. (Pubitemid 24195371)
14. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet. 2000;356:1154-1159.
15. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol. 1999;94:2390-2397. (Pubitemid 29420662)
16. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3: RESEARCH0034.
17. Green PH, Lefkowitch JH, Glickman RM, Riley JW, Quinet E, Blum CB. Apolipoprotein localization and quantitation in the human intestine. Gastroenterology. 1982;83:1223-1230. (Pubitemid 13235922)
18. Riepl RL, Lehnert P, Scharl A, et al. Effect of intraduodenal bile and Na-taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man. Scand J Gastroenterol. 1990;25:45-53. (Pubitemid 20018802)
19. Rehfeld JF, Sun G, Christensen T, Hillingso JG. The predominant cholecystokinin in human plasma and intestine is cholecystoki-nin-33. J Clin Endocrinol Metab. 2001;86:251-258. (Pubitemid 32109804)
20. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostat. 2003;4:249-264.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408. (Pubitemid 34164012)
22. Hussain MM, Fatma S, Pan X, Iqbal J. Intestinal lipoprotein assembly. Curr Opin Lipidol. 2005;16:281-285. (Pubitemid 40839756)
23. Mu H, Hoy CE. The digestion of dietary triacylglycerols. Prog Lipid Res. 2004;43:105-133. (Pubitemid 37487986)
24. Wong DM, Webb JP, Malinowski PM, Macri J, Adeli K. Proteomic profiling of the prechylomicron transport vesicle involved in the assembly and secretion of apoB-48-containing chylomicrons in the intestinal enterocytes. Proteomics. 2009;9:3698-3711.
25. Mansbach CM, Nevin P. Intracellular movement of triacylglycerols in the intestine. J Lipid Res. 1998;39:963-968. (Pubitemid 28222000)
26. Raybould HE, Glatzle J, Freeman SL, et al. Detection of macronutrients in the intestinal wall. Auton Neurosci. 2006;125: 28-33.
27. Glatzle J, Darcel N, Rechs AJ, Kalogeris TJ, Tso P, Raybould HE. Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway. Am J Physiol Regul Integr Comp Physiol. 2004;287:R354-R359. (Pubitemid 38970288)
28. Cartwright IJ, Higgins JA. Increased dietary triacylglycerol markedly enhances the ability of isolated rabbit enterocytes to secrete chylomicrons: an effect related to dietary fatty acid composition. J Lipid Res. 1999;40:1858-1866. (Pubitemid 29477256)
29. Kuksis A. Effect of dietary fat on formation and secretion of chylomicrons and other lymph lipoproteins. In: Kuksis A, Boca Raton FL ed. Fat absorption. CRC Press; 1987:135-166.
30. Hayashi H, Nutting DF, Fujimoto K, Cardelli JA, Black D, Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J Lipid Res. 1990;31:1613-1625.
31. Rodriguez MD, Kalogeris TJ, Wang XL, Wolf R, Tso P. Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats. Am J Physiol. 1997;272:R1170-R1177.
32. Apfelbaum TF, Davidson NO, Glickman RM. Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am J Physiol. 1987;252:G662-G666.
33. Feinle C, D'Amato M, Read NW. Cholecystokinin - a receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology. 1996;110:1379-1385. (Pubitemid 26134068)
34. Wormsley KG. Response to duodenal acidification in man. 3. Comparison with the effects of secretin and pancreozymin. Scand J Gastroenterol. 1970;5:353-360.